NCT03268148

Brief Summary

Neonates undergo several painful procedures and these pain experiences can alter clinical outcome and behavior. The investigators aim to investigate the analgesic effect of low level laser for procedural pain during heel lancing of term neonates.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
123

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Aug 2017

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2017

Completed
28 days until next milestone

First Submitted

Initial submission to the registry

August 29, 2017

Completed
2 days until next milestone

First Posted

Study publicly available on registry

August 31, 2017

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2019

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2019

Completed
Last Updated

February 27, 2020

Status Verified

February 1, 2020

Enrollment Period

1.9 years

First QC Date

August 29, 2017

Last Update Submit

February 26, 2020

Conditions

Keywords

neonatespainlow level laser

Outcome Measures

Primary Outcomes (1)

  • pain assessment

    latency of first cry, crying time, squeezing time, neonatal facial coding system(NFCS), Neonatal Pain, Agitation and Sedation Scale (NPASS)

    immediately after heel-lancing

Secondary Outcomes (1)

  • stress biomarker

    baseline, immediately after heel-lancing, 20 minutes after heel-lancing

Study Arms (2)

low level laser group

EXPERIMENTAL

LaserPen is applied to the local point for 20 seconds where heel-lancing will be performed in the low level laser group.

Device: LaserPen

breast milk group

NO INTERVENTION

Subjects in breast milk group are given 5ml expressed breast milk by mouth using a syringe tube inserted to the participant's oral cavity over a 2-minute period before heel-lancing.

Interventions

LaserPenDEVICE

low level laser is used before heel-lancing for newborn screening

Also known as: power 150mW, wavelength 810nm, RJ-laser
low level laser group

Eligibility Criteria

Age2 Days - 4 Days
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • healthy fullterm neonates (37-42 gestational age)
  • Apgar score \>= 7
  • will receive newborn screening

You may not qualify if:

  • \>42 or \< 37 gestational age
  • perinatal asphyxia
  • major malformations or any other disease that need intensive care
  • drug withdrawal received previous treatment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kaohsiung Chang Gung Memorial Hospital

Kaohsiung City, 833, Taiwan

Location

Related Publications (1)

  • Ou-Yang MC, Chen IL, Chen CC, Chung MY, Chen FS, Huang HC. Expressed breast milk for procedural pain in preterm neonates: a randomized, double-blind, placebo-controlled trial. Acta Paediatr. 2013 Jan;102(1):15-21. doi: 10.1111/apa.12045. Epub 2012 Nov 1.

MeSH Terms

Conditions

Pain, ProceduralPain

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Bei-yu Wu, doctor

    Chang Gung Memorial Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Two independent assessors blinded to intervention read the video, and then record vital signs and pain score. The videos are cut from heel-lancing to the end so that the assessors do not know whether the neonate receive low level laser or breast milk.
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: low level laser group and breast milk group
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Atteding doctor

Study Record Dates

First Submitted

August 29, 2017

First Posted

August 31, 2017

Study Start

August 1, 2017

Primary Completion

June 30, 2019

Study Completion

December 31, 2019

Last Updated

February 27, 2020

Record last verified: 2020-02

Locations